The interaction between acne vulgaris and the psyche

Cutis

Volumn 70, Issue 2, 2002, Pages 133-139

  Baldwin, Hilary E ^a,b  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACNE VULGARIS; ADAPTIVE BEHAVIOR; EMOTIONAL DISORDER; HOSPITALIZATION; HUMAN; MENTAL STRESS; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; REVIEW; UNITED STATES;

ACNE VULGARIS; ADAPTATION, PSYCHOLOGICAL; AFFECTIVE SYMPTOMS; HUMANS; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; STRESS, PSYCHOLOGICAL; UNITED STATES;

EID: 0036690617     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. White GM. Recent findings in the epidemiologic evidence, classification, and subtypes of acne vulgaris. J Am Acad Dermatol. 1998;39(suppl):S34-S37.
2. Sulzberger MB, Zaidems SH. Psychogenic factors in dermatological disorders. Med Clin North Am. 1948;32:669-673.
3. Feldman W, Hodgson C, Corber S, et al. Health concerns and health-related behaviours of adolescents. CMAJ. 1986;134:489-493.
4. Jowett S, Ryan T. Skin disease and handicap: an analysis of the impact of skin conditions. Soc Sci Med. 1985;20:425-429.
5. Gupta MA, Gupta AK, Schork NJ. Psychosomatic study of self-excoriate behaviour among male acne patients: preliminary observations. Int J Dermatol. 1994;33:846-848.
6. Gupta MA, Gupta AK. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol. 1998;139:846-850.
7. Morgan M, McCreedy R, Simpson J, et al. Dermatology quality of life scales - a measure of the impact of skin diseases. Br J Dermatol. 1997;136:202-206.
8. Koo J. The psychosocial impact of acne: patient's perceptions. J Am Acad Dermatol 1995;32(suppl):S26-S30.
9. Kellett SG, Gawkrodger DJ. The psychosocial and emotion impact of acne and the effect of treatment with isotretinoin. Br J Dermatol. 1999;140:273-282.
10. Wu SF, Kinder BN, Trunnell TN, et al. Role of anxiety and anger in acne patients: a relationship with the severity of the disorder. J Am Acad Dermatol. 1988;18:325-333.
11. Pearl A, Arroll B, Lello J, et al. The impact of acne: a study of adolescents' attitudes, perception and knowledge. N Z Med J. 1998;111:269-271.
12. Gupta MA, Gupta AK, Schork NJ, et al. Psychiatric aspects of the treatment of mild to moderate facial acne: some preliminary observations. Int J Dermatol. 1990;29:719-721.
13. Motley RJ, Finlay AY. How much disability is caused by acne? Clin Exp Dennatol. 1989;14:194-198.
14. Niemeier V, Kupfer J, Demmelbauer-Ebner M, et al. Coping with acne vulgaris evaluation of the chronic skin disorder questionnaire in patients with acne. Dermatology. 1998;193:108-115.
15. Rubinow DR, Peck GL, Squillace KM, et al. Reduced anxiety and depression in cystic acne patients after successful treatment with oral isotretinoin. J Am Acad Dermatol. 1987;17:25-32.
16. Newton JN, Mallon E, Klassen A, et al. The effectiveness of acne treatment: an assessment by patients of the outcome of therapy. Br J Dermatol. 1997:137:563-567.
17. Jordan R, Cummins C, Burls A. Laser resurfacing of the skin for the improvement of facial acne scarring: a systematic review of the evidence. Br J Dermatol. 2000;142:413-423.
18. Schulpis K, Georgala S, Papakonstantinou ED, et al. Psychological and sympatho-adrenal status in patients with cystic acne. J Eur Acad Dermatol Venereol. 1999;13:24-27.
19. Griesemer RD. Emotionally triggered disease in a dermatologic practice. Psychiatr Ann. 1978;8:407-412.
20. Lorenz TH, Graham DT, Wolf S. The relation of life stress and emotions to human sebum secretion and to the mechanism of acne vulgaris. J Lab Clin Med. 1953;41:11-28.
21. Hughes H, Brown BW, Lawlis GF, et al. Treatment of acne vulgaris by biofeedback, relaxation, and cognitive imagery. J Psychosom Res. 1983;27:185-191.
22. Koblenzer CS. Psychotherapy for intractable inflammatory dermatoses. J Am Acad Dermatol. 1995;32:609-612.
23. Krowchuk DP, Stancin T, Keskine R, et al. The psychosocial effects of acne on adolescents. Pediatr Dermatol. 1991;8:332-338.
24. Cunliffe WJ. Acne and unemployment [letter]. Br J Dermatol. 1986;115:386.
25. Lasek RJ, Chren MM. Acne vulgaris and the quality of life of adult dermatology patients. Arch Dermatol. 1998;134:454-458.
26. Gupta MA, Gupta AK, Schork NJ. Psychological factors affecting self-excoriative behavior in women with mild-to-moderate facial acne vulgaris. Psychosomatics. 1996;37:172-180.
27. Accutane [package insert]. Nutley, NJ: Roche Pharmaceuticals; 2000.
28. van der Meeren HL, van der Schaar WW, van den Hurk CM. The psychological impact of severe acne. Cutis. 1985;35:84-86.
29. Peck GL, Olsen TG, Butkus D, et al. Isotretinoin versus placebo in the treatment of cystic acne: a randomized double-blind study. J Am Acad Dermatol. 1982;6(4 pt 2 suppl):735-745.
30. Koo J. Is depression from isotretinoin real? Presented at: 26th Annual Hawaii Dermatology Seminar; February 1, 2002; Maui, Hawaii.
31. Jick SS, Kremers HM, Vasilakis-Scaramozza C. Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide. Arch Dermatol. 2000;136:1231-1236.
32. Blazer DG, Kessler RC, McGonagle KA, et al. The prevalence and distribution of major depression in a national community sample. Am J Psych. 1994:151:979-986.
33. Motley RJ, Finlay AY. Practical use of a disability index in the routine management of acne. Clin Exp Dermatol. 1992;17:1-3.
34. Malus M, LaChance PA, Lamy L, et al. Priorities in adolescent health care: the teenager's viewpoint. J Fam Pract. 1987:25:159-162.
35. Kligman AM. An overview of acne. J Invest Dermatol. 1974;62:268-287.
36. Gupta MA, Gupta AK. Olanzapine may be an effective adjunctive therapy in the management of acne excoriate: a case report. J Cut Med Surg. 2001;5:25-27.